Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Nuvation Bio Inc. publishes a filing, an earnings call transcript or a press release.

Get NUVB alerts

About Kim Blickenstaff

Kim Blickenstaff is recorded as Board Member at Nuvation Bio Inc. (NUVB) and Chairman at Tandem Diabetes Care Inc (TNDM) since March 6, 2020. The newest filing on record that lists Kim Blickenstaff as Board Member at Nuvation Bio Inc. (NUVB) is dated April 10, 2026. The proxy statement of Tandem Diabetes Care Inc reports total compensation of $10,544,957 for Kim Blickenstaff in fiscal 2019, including a base salary of $500,000. Disclosed compensation is on record for 3 fiscal years. Nuvation Bio Inc. is classified in the Biotechnology industry within the Healthcare sector. Tandem Diabetes Care Inc is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Nuvation Bio Inc. includes David Hung (CEO and Board Member), Moses Makunje (CFO and Chief Accounting Officer), Philippe Sauvage (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Nuvation Bio Inc.

Leadership on record at Tandem Diabetes Care Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2019 Tandem Diabetes Care Inc (TNDM) $500,000 $10,544,957
2018 Tandem Diabetes Care Inc (TNDM) $1 $2,983,485
2017 Tandem Diabetes Care Inc (TNDM) $583,495 $749,167

Recent activity

No call appearances or filed executive changes recorded yet.